Integrin-regulated FAK-Src signaling in normal and cancer cells - PubMed
Review
Integrin-regulated FAK-Src signaling in normal and cancer cells
Satyajit K Mitra et al. Curr Opin Cell Biol. 2006 Oct.
Abstract
Integrins can alter cellular behavior through the recruitment and activation of signaling proteins such as non-receptor tyrosine kinases including focal adhesion kinase (FAK) and c-Src that form a dual kinase complex. The FAK-Src complex binds to and can phosphorylate various adaptor proteins such as p130Cas and paxillin. In normal cells, multiple integrin-regulated linkages exist to activate FAK or Src. Activated FAK-Src functions to promote cell motility, cell cycle progression and cell survival. Recent studies have found that the FAK-Src complex is activated in many tumor cells and generates signals leading to tumor growth and metastasis. As both FAK and Src catalytic activities are important in promoting VEGF-associated tumor angiogenesis and protease-associated tumor metastasis, support is growing that FAK and Src may be therapeutically relevant targets in the inhibition of tumor progression.
Similar articles
-
Signal transduction by focal adhesion kinase in cancer.
Zhao J, Guan JL. Zhao J, et al. Cancer Metastasis Rev. 2009 Jun;28(1-2):35-49. doi: 10.1007/s10555-008-9165-4. Cancer Metastasis Rev. 2009. PMID: 19169797 Review.
-
New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
Cox BD, Natarajan M, Stettner MR, Gladson CL. Cox BD, et al. J Cell Biochem. 2006 Sep 1;99(1):35-52. doi: 10.1002/jcb.20956. J Cell Biochem. 2006. PMID: 16823799 Review.
-
Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE. Hui AY, et al. J Cell Biochem. 2009 Aug 15;107(6):1168-81. doi: 10.1002/jcb.22219. J Cell Biochem. 2009. PMID: 19533669
-
Cowell LN, Graham JD, Bouton AH, Clarke CL, O'Neill GM. Cowell LN, et al. Oncogene. 2006 Dec 7;25(58):7597-607. doi: 10.1038/sj.onc.1209747. Epub 2006 Jun 26. Oncogene. 2006. PMID: 16799644
-
Madan R, Smolkin MB, Cocker R, Fayyad R, Oktay MH. Madan R, et al. Hum Pathol. 2006 Jan;37(1):9-15. doi: 10.1016/j.humpath.2005.09.024. Hum Pathol. 2006. PMID: 16360410
Cited by
-
Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis.
Lee YJ, Kim IS, Park SA, Kim Y, Lee JE, Noh DY, Kim KT, Ryu SH, Suh PG. Lee YJ, et al. Mol Ther. 2013 May;21(5):1004-13. doi: 10.1038/mt.2013.30. Epub 2013 Mar 19. Mol Ther. 2013. PMID: 23511245 Free PMC article.
-
Su B, Gao L, Meng F, Guo LW, Rothschild J, Gelman IH. Su B, et al. Oncogene. 2013 Apr 18;32(16):2016-26. doi: 10.1038/onc.2012.218. Epub 2012 Jun 18. Oncogene. 2013. PMID: 22710722 Free PMC article.
-
Schumpert B, García MG, Wessel GM, Wordeman L, Hille MB. Schumpert B, et al. Mech Dev. 2013 Apr-May;130(4-5):290-303. doi: 10.1016/j.mod.2012.12.003. Epub 2013 Jan 8. Mech Dev. 2013. PMID: 23313141 Free PMC article.
-
Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T. Kong X, et al. PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876288 Free PMC article.
-
Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion.
Huveldt D, Lewis-Tuffin LJ, Carlson BL, Schroeder MA, Rodriguez F, Giannini C, Galanis E, Sarkaria JN, Anastasiadis PZ. Huveldt D, et al. PLoS One. 2013;8(2):e56505. doi: 10.1371/journal.pone.0056505. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457577 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous